Patents by Inventor Simon Westbrook

Simon Westbrook has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260139031
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein (NBP)-Fc fusion protein comprising a p75NTR(NBP) portion and an immunoglobulin portion. In certain embodiments, the p75NTR(NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Application
    Filed: November 21, 2025
    Publication date: May 21, 2026
    Inventors: Simon WESTBROOK, Jason RUTT
  • Publication number: 20260078167
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein (NBP)-Fc fusion protein comprising a p75NTR(NBP) portion and an immunoglobulin portion. In certain embodiments, the p75NTR(NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Application
    Filed: November 21, 2025
    Publication date: March 19, 2026
    Inventors: Jason RUTT, Simon WESTBROOK
  • Publication number: 20260062459
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein (NBP)-Fc fusion protein comprising a p75NTR(NBP) portion and an immunoglobulin portion. In certain embodiments. the p75NTR(NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Application
    Filed: August 7, 2025
    Publication date: March 5, 2026
    Inventor: Simon WESTBROOK
  • Publication number: 20250177485
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein, p75NTR (NBP), for use in the treatment of pain and/or a symptom of pain.
    Type: Application
    Filed: December 10, 2024
    Publication date: June 5, 2025
    Inventor: Simon WESTBROOK
  • Patent number: 12201672
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein, p75NTR(NBP), for use in the treatment of pain and/or a symptom of pain.
    Type: Grant
    Filed: July 15, 2020
    Date of Patent: January 21, 2025
    Assignee: Levicept LTD
    Inventor: Simon Westbrook
  • Publication number: 20230093211
    Abstract: The present invention relates to a new therapeutic use of a p75NTR neurotrophin binding protein and related molecules in the treatment of osteoarthritis.
    Type: Application
    Filed: April 20, 2022
    Publication date: March 23, 2023
    Inventor: Simon WESTBROOK
  • Patent number: 11339202
    Abstract: The present invention relates to a new therapeutic use of a p75NTR neurotrophin binding protein and related molecules in the treatment of osteoarthritis.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: May 24, 2022
    Assignee: LEVICEPT LIMITED
    Inventor: Simon Westbrook
  • Publication number: 20210238256
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein (NBP)-Fc fusion protein comprising a p75NTR(NBP) portion and an immunoglobulin portion. In certain embodiments, the p75NTR(NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Application
    Filed: March 24, 2021
    Publication date: August 5, 2021
    Inventor: Simon WESTBROOK
  • Patent number: 10988526
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein (NBP)-Fc fusion protein comprising a p75NTR(NBP) portion and an immunoglobulin portion. In certain embodiments, the p75NTR(NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: April 27, 2021
    Assignee: Levicept Limited
    Inventor: Simon Westbrook
  • Publication number: 20210060123
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein, p75NTR(NBP), for use in the treatment of pain and/or a symptom of pain.
    Type: Application
    Filed: July 15, 2020
    Publication date: March 4, 2021
    Inventor: Simon WESTBROOK
  • Patent number: 10751389
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein, p75NTR(NBP), for use in the treatment of pain and/or a symptom of pain.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: August 25, 2020
    Assignee: Levicept LLD
    Inventor: Simon Westbrook
  • Patent number: 10683339
    Abstract: The present invention relates to a new p75NTR neurotrophin binding protein (NBP)-Fc fusion protein comprising a p75NTR (NBP) portion and an immunoglobulin portion. In certain embodiments, the p75NTR (NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: June 16, 2020
    Assignee: Levicept Limited
    Inventor: Simon Westbrook
  • Publication number: 20180273603
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein (NBP)-Fc fusion protein comprising a p75NTR(NBP) portion and an immunoglobulin portion. In certain embodiments, the p75NTR(NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Application
    Filed: December 15, 2017
    Publication date: September 27, 2018
    Inventor: Simon WESTBROOK
  • Publication number: 20180170995
    Abstract: The present invention relates to a new p75NTR neurotrophin binding protein (NBP)-Fc fusion protein comprising a p75NTR (NBP) portion and an immunoglobulin portion. In certain embodiments, the p75NTR (NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Application
    Filed: March 18, 2016
    Publication date: June 21, 2018
    Inventor: Simon WESTBROOK
  • Publication number: 20180161392
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein, p75NTR(NBP), for use in the treatment of pain and/or a symptom of pain.
    Type: Application
    Filed: August 18, 2017
    Publication date: June 14, 2018
    Inventor: Simon WESTBROOK
  • Patent number: 9873728
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein(NBP)-Fc fusion protein comprising a p75NTR(NBP) portion and an immunoglobulin portion. In certain embodiments, the p75NTR(NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: January 23, 2018
    Assignee: LEVICEPT LTD.
    Inventor: Simon Westbrook
  • Patent number: 9764000
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein, p75NTR(NBP), for use in the treatment of pain and/or a symptom of pain.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: September 19, 2017
    Assignee: Levicept LTD
    Inventor: Simon Westbrook
  • Publication number: 20170204156
    Abstract: The present invention relates to a new therapeutic use of a p75NTR neurotrophin binding protein and related molecules in the treatment of osteoarthritis.
    Type: Application
    Filed: July 17, 2015
    Publication date: July 20, 2017
    Inventor: Simon WESTBROOK
  • Publication number: 20160222082
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein(NBP)-Fc fusion protein comprising a p75N-TR(NBP) portion and an immunoglobulin portion. In certain embodiments, the p75NTR(NBP)-Fc fusion protein is for use in the treatment of pain and/or a symptom of pain.
    Type: Application
    Filed: September 18, 2014
    Publication date: August 4, 2016
    Inventor: Simon Westbrook
  • Publication number: 20150037335
    Abstract: The present invention relates to a p75NTR neurotrophin binding protein, p75NTR(NBP), for use in the treatment of pain and/or a symptom of pain.
    Type: Application
    Filed: March 14, 2013
    Publication date: February 5, 2015
    Inventor: Simon Westbrook